JLE

Epileptic Disorders

MENU

The clinical pharmacology of traditional antiepileptic drugs Volume 16, numéro 4, December 2014

  • [Arzimanoglou et al., 2010] Arzimanoglou A., Ben-Menachem E., Cramer J., Glauser T., Seeruthun R., Harrison M. The evolution of antiepileptic drug development and regulation. Epileptic Disord. 2010;12:3-15. 10.1684/epd.2010.0303 1
  • [Beydoun et al., 2008] Beydoun A.A., Nasreddine W.M., Albini F., Engel J., Pedley T.A. Oxcarbazepine. Epilepsy. A comprehensive textbook. Philadelphia: Wolters Kluwer; Lippincott, Williams & Wilkins; 20081593-1598. 2nd ed
  • [Bromfield, 2008] Bromfield E.B., Engel J., Pedley T.A. Ethosuximide. Epilepsy. A comprehensive textbook. Philadelphia: Wolters Kluwer; Lippincott, Williams & Wilkins; 20081557-1560. 2nd ed
  • [Dickinson et al., 1999] Dickinson R.G., Eadie M.J., Vajda F.J.E., Eadie M.J., Vajda F.J.E. Carbamazepine. Antiepileptic drugs. Pharmacology and therapeutics. Berlin: Heidelberg: Springer-Verlag; 1999267-317.
  • [Eadie and Hooper, 2002] Eadie M.J., Hooper W.D., Levy R.H., Mattson R.H., Meldrum B.S., Perucca E. Phenobarbital and other barbiturates. Methylphenobarbital. Antiepileptic drugs. Philadelphia: Lippincott, Williams & Wilkins; 2002541-547. 5th ed
  • [Eadie and Kwan, 2008] Eadie M.J., Kwan P., Engel J., Pedley T.A. Phenobarbital and other barbiturates. Epilepsy. A comprehensive textbook. Philadelphia: Wolters Kluwer; Lippincott, Williams & Wilkins; 20081599-1607. 2nd ed
  • [Eadie and Vajda, 1999] Eadie M.J., Vajda F.J.E., Eadie M.J., Vajda F.J.E. Older anticonvulsants continuing in use but with limited advance in knowledge. Antiepileptic drugs. Pharmacology and therapeutics. Berlin: Heidelberg: Springer-Verlag; 1999189-228.
  • [Faught and Limdi, 2009] Faught E., Limdi N., Shorvon S., Perucca E., Engrl J. Jr. Oxcarbazepine. The treatment of epilepsy. Chichester: Wiley-Blackwell; 2009575-584. 3rd ed
  • [Fertig and Mattson, 2008] Fertig E.J., Mattson R.H., Engel J., Pedley T.A. Carbamazepine. Epilepsy. A comprehensive textbook. Philadelphia: Wolters Kluwer; Lippincott, Williams & Wilkins; 20081543-1555. 2nd ed
  • [Fincham and Schottelius, 2002] Fincham R.W., Schottelius D.D., Levy R.H., Mattson R.H., Meldrum B.S., Perucca E. Primidone. Antiepileptic drugs. Philadelphia: Lippincott, Williams & Wilkins; 2002621-635. 5th ed
  • [Genton et al., 2001] Genton P., Bauer J., Duncan S. On the association between valproate and polycystic ovary syndrome. Epilepsia. 2001;42:295-304.
  • [Glauser and Perucca, 2009] Glauser T.A., Perucca E., Shorvon S., Perucca E., Engrl J. Jr. Ethosuximide. The treatment of epilepsy. Chichester: Wiley-Blackwell; 2009499-509. 3rd ed
  • [Isojarvi et al., 1998] Isojarvi I.T., Tattya J., Myllylla V.V. Valproate, lamotrigine and insulin-mediated risks in women with epilepsy. Ann Neurol. 1998;43:446-451.
  • [Jentink et al., 2010] Jentink J., Loane M.A., Dolk H. Valproic acid monotherapy in pregnancy and major congenital malformations. New Eng J Med. 2010;362:2185-2193.
  • [Kilpatrick, 1999] Kilpatrick C., Eadie M.J., Vajda F.J.E. Benzodiazepines. Antiepileptic drugs. Pharmacology and therapeutics. Berlin; Heidelberg; New York: Springer-Verlag; 1999395-423.
  • [Kutt and Harden, 1999] Kutt H., Harden C.L., Eadie M.J., Vajda F.J.E. Phenytoin and congeners. Antiepileptic drugs. Pharmacology and therapeutics. Berlin: Heidelberg; New York: Springer-Verlag; 1999229-265.
  • [Loscher and Schmidt, 2006] Loscher W., Schmidt D. Experimental and clinical evidence for loss of effect (tolerance) during prolonged treatment with antiepileptic drugs. Epilepsia. 2006;47:1284-1353.
  • [Macdonald, 2003] Macdonald R.L., Levy R.H., Mattson R.H., Meldrum B.S., Perucca E. Benzodiazepines. Mechanisms of action. Antiepileptic drugs. Philadelphia: Lippincott, Williams & Wilkins; 2003179-186. 5th ed
  • [Marson et al., 2007] Marson A.G., Al-Kharusi A.M., Alwaidh M. SANAD studies on effectiveness of valproate, lamotrigine or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet. 2007;369:1106-1126.
  • [Meador et al., 2009] Meador K.J., Baker G.A., Browning N. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. New Eng J Med. 2009;360:1597-1605.
  • [Michelucci et al., 2009] Michelucci R., Pasini E., Tassinari C.A., Shorvon S., Perucca E., Engrl J. Jr. Phenobarbital, primidone and other barbiturates. The treatment of epilepsy. Chichester: Wiley-Blackwell; 2009585-603. 3rd ed
  • [O’Brien et al., 2001] O’Brien T.J., Meara F., Matthews H., Vajda F.J.E. A prospective study of local cutaneous reactions in patients receiving intravenous phenytoin. Neurology. 2001;57:158-160.
  • [Panayiotopolous, 2005] Panayiotopolous C.P. The epilepsies. Seizures, syndromes and management. Chipping Norton (Oxfordshire, Great Britain): Bladon Medical Publishing; 2005.
  • [Patsalos and Perucca, 2003a] Patsalos P.N., Perucca E. Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurol. 2003;2:347-356.
  • [Patsalos and Perucca, 2003b] Patsalos P.N., Perucca E. Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurol. 2003;2:473-481.
  • [Schmidt and Wilensky, 2008] Schmidt D., Wilensky A.J., Engel J., Pedley T.A. Benzodiazepines. Epilepsy. A comprehensive textbook. Philadelphia: Wolters Kluwer; Lippincott, Williams & Wilkins; 20081531-1541. 2nd ed
  • [Shen and Levy, 1999] Shen D.D., Levy R.H., Eadie M.J., Vajda F.J.E. Valproate. Antiepileptic drugs. Pharmacology and therapeutics. Berlin: Heidelberg: Springer-Verlag; 1999359-373.
  • [Silaanpaa et al., 2009] Silaanpaa M., Haataja L., Tomson T., Johanessen S.I., Shorvon S., Perucca E., Engrl J. Jr. Carbamazepine. The treatment of epilepsy. Chichester: Wiley-Blackwell; 2009459-474. 3rd ed
  • [Stern et al., 2008] Stern J.M., Perucca E., Browne T., Engel J., Pedley T.A. Phenytoin, fosphenytoin, and other hydantoins. Epilepsy. A comprehensive textbook. Philadelphia: Wolters Kluwer; Lippincott, Williams & Wilkins; 20081609-1627. 2nd ed
  • [Tomson et al., 2011] Tomson T., Battino D., Bonizzoni E. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol. 2011;10:609-617.
  • [Treiman, 1987] Treiman D.T., Brodie M.J., Treiman D.M. Status epilepticus. Modern management of epilepsy. London: Tindall; 1987.
  • [Vajda, 2000] Vajda F.J.E. Monitoring antiepileptic drug therapy with serum level measurements. Medial J Australia. 2000;187:581-582.
  • [Vajda et al., 2010] Vajda F.J., Hitchcock A.A., Graham J., O’Brien T.J., Lander C.M., Eadie M.J. The teratogenic risk of antiepileptic drug polytherapy. Epilepsia. 2010;51:805-810.
  • [Wallis et al., 1968] Wallis W., Kutt H., McDowell F. Intravenous diphenylhydantoin in the treatment of acute repetitive seizures. Neurology. 1968;18:513-525.